PhaseBio Pharmaceuticals, Inc. (PHAS)

Depreciation & Amortization

$603.00K

Quarterly · Period ending: · USD

PHAS logo

PHAS Depreciation & Amortization

Latest reported$603.00K
PHAS Quarterly Depreciation & Amortization ($28.00K → $603.00K)
High-resolution chart · PNG

PHAS depreciation & amortization history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

PhaseBio Pharmaceuticals, Inc. Depreciation & Amortization — Quarterly (USD)
Period endingDepreciation & Amortization (USD)
603,000
601,000
606,000
130,000
583,000
474,000
342,000
55,000
57,000
54,000
50,000
50,000
43,000
31,000
23,000
28,000
27,000
27,000
28,000
28,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.